Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
Looks like we may drop below 1000p today at this rate. Gut feel is that we will get to 850 - 950p and level off for a few weeks.
Does anyone have a link to yesterday's presentation / webinar?
Thanks
This is heading north tomorrow.
Long term holder here checking in. I’ve not followed SNG for a few months now but still own a chunk of shares.
Does anyone have the latest guidance from Synairgen on when to expect the Phase 3 trial to complete?
Thanks
So £100m plus approx £80m DHSC. At £180m revenue for the year that compares to a current market cap of £210m, giving a PE of 1.16. Insane value here!
Porks, when you break it down like that this price seems like the bargain of the decade! Hugely undervalued at this price.
What we saw in the last RNS was very different to previous. Some positivity and foresight. This is what the market has wanted and not received in the past. If this is maintained, I believe we will see new highs.
Thanks Shins. So Phase 3 is still recruiting? Did they say that we would hear when dosing was complete, and we haven't yet had that message?
Hi All
I am holding a reasonable amount of SNG however have been out of the loop for the last couple of months. I know the obviously know the overall investment case, but could anybody give a quick synopsis on latest developments, what we are waiting for and when it is expected?
This may be useful for anybody looking in to the board considering an investment.
Thanks.
NCYT discussed - have a listen.
Let's think ahead guys. What is next for NCYT.
This was a blow but now that the bad news is out of the way, what lays ahead?
- Next gen LFT - I believe this was previously RNS'd.
- Private Sector contracts.
- Genomic testing?
Thanks Shaun.
Any indication is useful.
Hi All
I’ve not had time to follow discussion a lot recently. Do we have a date for the release of end of year results / financial update? I seem to remember it was to be around this time.
Thanks
AstraZeneca people are also attendees....
Bluelight, it is incredible. A 'Novatalk' with this calibre of speaker and links to NHS. It shows how far the company has come in 12 months. This wouldn't have been dreamt of this time last year.
Matt Han****, Mandy, and a whole host of other NCYT employees showing as attendees. Chartwell consulting also.
This would appear to be quite an important talk.
No way of knowing who is holding troublesome, but just interested to know who has stuck around since the early days and still has conviction.
Hi All - Long time lurker and investor here. First foray into NCYT back in February last year and still holding most of my shares in value, having top sliced at various times through the year. Looking to run the remainder for the long term with NCYT being so materially undervalued, and clearly with such a big rise ahead of us, up to new highs. What is happening now is reminiscent of what we have seen with the the SP many times over the last year. We have had lots of falls based on no news, fear, and external factors. Never has the SP dropped on bad news or poor results from the company, all drops have been investor/trader driven, fear and panic, and or external influence. Case in point being the Gov announcement last night and the effect it has had today.
The SP has indeed been heavily driven by hype in the past which we seemingly do not have at the moment and I feel are now beyond on AIM. We do appear to be in a transition phase between it being a hot hype driven stock, and a more ordinary investment based on solid fundamentals appealing to a different calibre of investor all together. This transition phase is a tough place to be at present but I have not an ounce of worry that the SP will rise and rise to new highs which reflect the huge profits the company is making in due course. We of course need updates from the company on new contracts, developments, innovation and M&A, which I am hoping will kick off on Friday (or prior with an RNS) during the presentation with the top UK health experts.
Sit tight all and ride out these dark days all. The good times will come in due course.
I wonder how many holders we have who got in this time last year? I still recognise a number of names.
Chaps we have figures which are higher than broker forecasts. This is excellent news and certainly installs confidence for me. We should re rate to the higher SP quoted in the forecasts in due course. More news will boost further.
Strong hold!
I think the wording and some of the details of upcoming news is scant for a reason. This allows for incremental release via RNS which could begin very soon with the DHSC extension. This will foster a slower and steadier SP growth and bolster confidence in Novacyt far better than if they laid it all on thick in this one RNS and then said nothing for the next couple of months. That would only spike and drop the SP, what is being done is the preferred method and I expect steady growth into this year.
Thanks Max. It makes sense, though I am a little baffled at the massive price action over the last few days for just that reason. However as you say, a perfect storm where factors have become such that there is huge interest in crypto of late and most related stocks are doing well.